Search results
Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?
Designed to provide broad exposure to the Materials - Broad segment of the equity market, the Fidelity MSCI Materials Index ETF (FMAT) is a passively managed exchange traded fund launched on
TJX (TJX) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Wall Street analysts expect TJX (TJX) to post quarterly earnings of $1.18 per share in its upcoming report, which indicates a year-over-year increase of 7.3%. Revenues are expected to be $15.14
Delta Air Lines (DAL) Dips More Than Broader Market: What You Should Know
Delta Air Lines (DAL) ended the recent trading session at $89.20, demonstrating a -2.31% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of
Should iShares Russell 1000 ETF (IWB) Be on Your Investing Radar?
The iShares Russell 1000 ETF (IWB) was launched on May 15, 2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Blend segment of the US equity
Should You Invest in the Invesco S&P 500 Equal Weight Energy ETF (RSPG)?
The Invesco S&P 500 Equal Weight Energy ETF (RSPG) was launched on November 1, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Energy - Broad segment of
Should Direxion NASDAQ-100 Equal Weighted Index ETF (QQQE) Be on Your Investing Radar?
Designed to provide broad exposure to the Large Cap Growth segment of the US equity market, the Direxion NASDAQ-100 Equal Weighted Index ETF (QQQE) is a passively managed exchange traded fund
Is iShares MSCI USA Quality Factor ETF (QUAL) a Strong ETF Right Now?
Designed to provide broad exposure to the Style Box - All Cap Blend category of the market, the iShares MSCI USA Quality Factor ETF (QUAL) is a smart beta exchange traded fund launched on
Can Better Japan Profitability Support Aflac's Q2 Earnings Beat?
Insurance provider Aflac Incorporated AFL is set to report its second-quarter 2026 results on Aug. 6, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings
Can Higher Occupancy Help Encompass Health Counter Rising Costs in Q2?
Hospital operator Encompass Health Corporation EHC is set to report second-quarter 2026 results on Aug. 5, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s
Can MetLife Deliver a Q2 Earnings Beat on Group Benefits Strength?
Insurance provider MetLife, Inc. MET is set to report its second-quarter 2026 results on Aug. 5, 2026, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
Launched on November 1, 2006, the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) is a passively managed exchange traded fund designed to provide a broad exposure to the Consumer Staples -
Is JPMorgan Diversified Return Emerging Markets Equity ETF (JPEM) a Strong ETF Right Now?
Designed to provide broad exposure to the Broad Emerging Market ETFs category of the market, the JPMorgan Diversified Return Emerging Markets Equity ETF (JPEM) is a smart beta exchange traded fund
Should Invesco RAFI US 1500 Small-Mid ETF (PRFZ) Be on Your Investing Radar?
Launched on September 20, 2006, the Invesco RAFI US 1500 Small-Mid ETF (PRFZ) is a passively managed exchange traded fund designed to provide a broad exposure to the Small Cap Blend segment of the
Buy Microchip Stock Before Q1 Earnings? Here's What to Know
Microchip MCHP is set to report its first-quarter fiscal 2027 results on Aug. 6.For the to-be-reported quarter, MCHP expects revenues between $1.442 billion and $1.469 billion. The Zacks Consensus
Should You Buy, Hold or Sell Realty Income Stock Before Q2 Earnings?
Realty Income Corporation O, a leader in the net lease sector, is slated to release second-quarter 2026 results on Aug. 5, after market close. The Zacks Consensus Estimate for the to-be-reported
Travere Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Travere Therapeutics, Inc.? Here are five stocks we like better.
- Record FILSPARI performance: Travere reported $169.6 million in total second-quarter revenue
Should You Invest in the Global X U.S. Infrastructure Development ETF (PAVE)?
The Global X U.S. Infrastructure Development ETF (PAVE) was launched on March 6, 2017, and is a passively managed exchange traded fund designed to offer broad exposure to the Utilities -
Is Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) a Strong ETF Right Now?
Designed to provide broad exposure to the Style Box - Mid Cap Blend category of the market, the Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) is a smart beta exchange traded fund launched on
Here's What Key Metrics Tell Us About Medline (MDLN) Q2 Earnings
For the quarter ended June 2026, Medline (MDLN) reported revenue of $7.69 billion, representing no change compared to the same period last year. EPS came in at $0.50, compared to $0 in the year-ago
Global Partners Gears Up for Q2 Earnings: What's in the Cards?
Global Partners LP GLP is set to release second-quarter 2026 results on Aug. 7. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of $1.24 per share on revenues of


